Glucose Differences Between the Left Arm and Right Arm in Diabetic Patients Using a Continuous Glucose Monitor
Status unconfirmed · Not applicable
Conditions studied: Diabetes
In brief
Continuous glucose monitoring (CGM) is an emerging field for diabetes management. CGMs are small devices primarily placed on a patient's upper arm that allow providers and patients to individualize therapy by looking at real time glucose levels. While the accuracy of these devices is extensively researched, there are no large-scale studies evaluating the differences between left and right arm glucose readings in the diabetic population. Additionally cinnamon and aloe vera are supplements commonly used by diabetic patients to help improve glycemic control. However, there remains a shortage of studies researching the effects of cinnamon and aloe vera on diabetic patients' glycemic control. The purpose of this study is to determine if there is a difference between glucose levels in the right arm and left arm in diabetic patients and to evaluate if cinnamon and aloe vera supplements impact glycemic control in diabetic patients.
Key facts
- Study ID
- NCT04790760
- Run by
- University of the Pacific
- People needed
- 10
- Starts
- 2021-03-01
- Expected to finish
- 2022-02-01
- Last updated by the study team
- 2021-03-10
Who can join
Age: 18 and older, up to 65. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Adult 18-65 years of age
- Diagnosed with type 2 diabetes
- Willing to wear CGM for 6 weeks on both arms
- Willing to come in for 4 office visits over 6 weeks
- Willing to consume assigned supplement twice a day for 4 weeks
- Willing to receive and respond to daily text messages or maintain a daily study log of supplement consumption
- Have active health insurance
- Willing to refrain from any heat therapy for the duration of the study
- Willing to refrain from taking any other supplements that are deemed by the investigator to alter glucose for the duration of the study
- Willing to refrain from consuming ascorbic acid and salicylic acid for the duration of the study due to a known interaction with CGMs
- Be able to self-monitor blood glucose with finger-stick method
- Have a baseline HbA1c > 6.5%
You may not qualify if…
- Any active dermatologic condition on the upper arms
- Implanted medical devices (i.e. pacemaker)
- Critically ill or dialysis patients
- Planned magnetic resonance imaging screening, computed tomography scan, x-ray imaging or high-frequency electrical heat treatment during study period
- Current systemic infections
- Participants who are unable to fully understand the study or consent process will not be included in the study due to the lack of a qualified medical translator
- Change in diabetic medication regimen within the previous 30 days (except insulin)
- Self-identified allergy to cinnamon or aloe vera
- Refusal to sign the informed consent document
- Pregnant, planned-pregnancy during study period or currently breast-feeding
- History of hypoglycemic episodes warranting medical attention experienced in the last 30 days
Where it is running
- Manshadi Heart Institute, Inc. — Stockton, California, United States (enrolling)
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.